Myriad Genetics (MYGN) Tops Q1 EPS by 5c, Beats on Revenues; Offers FY18 EPS Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- Nasdaq leads Wall Street gains as SpaceX, Super Micro boost AI sentiment
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
- SpaceX, Tesla shares rise after Musk says committees exploring possible merger
- Brent falls as Iran's president discusses mediation with Pakistani army chief
| Myriad Genetics, Inc. (NASDAQ: MYGN) | Delayed: 5.57 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $5.57 | 52 Week High | $45.34 | |||
| Open | $5.57 | 52 Week Low | $15.92 | |||
| Day High | $5.57 | P/E | 2.39 | |||
| Day Low | $5.57 | EPS | $2.33 | |||
| Volume | 2,515 | |||||
